These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 22586253)

  • 1. Arterolane maleate plus piperaquine phosphate for treatment of uncomplicated Plasmodium falciparum malaria: a comparative, multicenter, randomized clinical trial.
    Valecha N; Krudsood S; Tangpukdee N; Mohanty S; Sharma SK; Tyagi PK; Anvikar A; Mohanty R; Rao BS; Jha AC; Shahi B; Singh JP; Roy A; Kaur P; Kothari M; Mehta S; Gautam A; Paliwal JK; Arora S; Saha N
    Clin Infect Dis; 2012 Sep; 55(5):663-71. PubMed ID: 22586253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Efficacy and Safety of Arterolane Maleate-Piperaquine Phosphate Dispersible Tablets in Comparison With Artemether-Lumefantrine Dispersible Tablets in Pediatric Patients With Acute Uncomplicated Plasmodium falciparum Malaria: A Phase 3, Randomized, Multicenter Trial in India and Africa.
    Toure OA; Mwapasa V; Sagara I; Gaye O; Thompson R; Maheshwar AV; Mishra P; Behra N; Tshefu AK; Das RR; Anvikar AR; Sharma P; Roy A; Sharma SK; Nasa A; Jalali RK; Valecha N;
    Clin Infect Dis; 2017 Oct; 65(10):1711-1720. PubMed ID: 29020247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the safety and efficacy of fixed-dose combination of arterolane maleate and piperaquine phosphate with chloroquine in acute, uncomplicated Plasmodium vivax malaria: a phase III, multicentric, open-label study.
    Valecha N; Savargaonkar D; Srivastava B; Rao BH; Tripathi SK; Gogtay N; Kochar SK; Kumar NB; Rajadhyaksha GC; Lakhani JD; Solanki BB; Jalali RK; Arora S; Roy A; Saha N; Iyer SS; Sharma P; Anvikar AR
    Malar J; 2016 Jan; 15():42. PubMed ID: 26818020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of fixed dose combination of arterolane maleate and piperaquine phosphate dispersible tablets in paediatric patients with acute uncomplicated Plasmodium falciparum malaria: a phase II, multicentric, open-label study.
    Toure OA; Rulisa S; Anvikar AR; Rao BS; Mishra P; Jalali RK; Arora S; Roy A; Saha N; Iyer SS; Sharma P; Valecha N
    Malar J; 2015 Nov; 14():469. PubMed ID: 26608469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Phase 3, Double-Blind, Randomized Study of Arterolane Maleate-Piperaquine Phosphate vs Artemether-Lumefantrine for Falciparum Malaria in Adolescent and Adult Patients in Asia and Africa.
    Toure OA; Valecha N; Tshefu AK; Thompson R; Krudsood S; Gaye O; Rao BHK; Sagara I; Bose TK; Mohanty S; Rao BS; Anvikar AR; Mwapasa V; Noedl H; Arora S; Roy A; Iyer SS; Sharma P; Saha N; Jalali RK; ; Tiacoh L; Enosse S; Tangpukdee N; Kokolomami J; Ndiaye JL; Rao D; Yumva NN; Sidibe B; Mohanty R; Jha AC; Nyirenda M; Starzengruber P; Swoboda P
    Clin Infect Dis; 2016 Apr; 62(8):964-971. PubMed ID: 26908796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of arterolane maleate following multiple oral doses in adult patients with P. falciparum malaria.
    Gautam A; Ahmed T; Sharma P; Varshney B; Kothari M; Saha N; Roy A; Moehrle JJ; Paliwal J
    J Clin Pharmacol; 2011 Nov; 51(11):1519-28. PubMed ID: 21148048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arterolane-piperaquine-mefloquine versus arterolane-piperaquine and artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a single-centre, open-label, randomised, non-inferiority trial.
    Hamaluba M; van der Pluijm RW; Weya J; Njuguna P; Ngama M; Kalume P; Mwambingu G; Ngetsa C; Wambua J; Boga M; Mturi N; Lal AA; Khuroo A; Taylor WRJ; Gonçalves S; Miotto O; Dhorda M; Mutinda B; Mukaka M; Waithira N; Hoglund RM; Imwong M; Tarning J; Day NPJ; White NJ; Bejon P; Dondorp AM
    Lancet Infect Dis; 2021 Oct; 21(10):1395-1406. PubMed ID: 34111412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of fixed dose combination of arterolane maleate and piperaquine phosphate in comparison with chloroquine phosphate in children with acute uncomplicated
    Valecha N; Goyal VK; Mishra DN; Das RR; Jauhri N; Bhardwaj AC; Khurana O; Choudhury R; Pandey M; Baliga BS; Ghosh SK; Srivastava B; Soans ST; Bahl RK; Punj A; Roy A; Sharma SK; Nasa A; Jalali RK; Anvikar AR
    J Vector Borne Dis; 2020; 57(3):213-220. PubMed ID: 34472504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arterolane, a new synthetic trioxolane for treatment of uncomplicated Plasmodium falciparum malaria: a phase II, multicenter, randomized, dose-finding clinical trial.
    Valecha N; Looareesuwan S; Martensson A; Abdulla SM; Krudsood S; Tangpukdee N; Mohanty S; Mishra SK; Tyagi PK; Sharma SK; Moehrle J; Gautam A; Roy A; Paliwal JK; Kothari M; Saha N; Dash AP; Björkman A
    Clin Infect Dis; 2010 Sep; 51(6):684-91. PubMed ID: 20687837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
    Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
    Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The structure-activity relationship of the antimalarial ozonide arterolane (OZ277).
    Dong Y; Wittlin S; Sriraghavan K; Chollet J; Charman SA; Charman WN; Scheurer C; Urwyler H; Santo Tomas J; Snyder C; Creek DJ; Morizzi J; Koltun M; Matile H; Wang X; Padmanilayam M; Tang Y; Dorn A; Brun R; Vennerstrom JL
    J Med Chem; 2010 Jan; 53(1):481-91. PubMed ID: 19924861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of efficacy and safety of artesunate-lumefantrine vs. artemether-lumefantrine fixed-dose combination in the treatment of uncomplicated Plasmodium falciparum malaria.
    Pareek A; Chandurkar N; Srivastav V; Lakhani J; Karmakar PS; Basu S; Ray A; Pednekar S; Gupta PB; Suthar N; Lakhani S
    Trop Med Int Health; 2013 May; 18(5):578-87. PubMed ID: 23489465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized clinical trial comparing safety, clinical and parasitological response to artemether-lumefantrine and chlorproguanil-dapsone in treatment of uncomplicated malaria in pregnancy in Mulago hospital, Uganda.
    Kaye DK; Nshemerirwe R; Mutyaba TS; Ndeezi G
    J Infect Dev Ctries; 2008 Apr; 2(2):135-9. PubMed ID: 19738339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomised trial to assess the safety and efficacy of artemether-lumefantrine (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwanda.
    Fanello CI; Karema C; van Doren W; Van Overmeir C; Ngamije D; D'Alessandro U
    Trans R Soc Trop Med Hyg; 2007 Apr; 101(4):344-50. PubMed ID: 17005222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arterolane-based combinations for the treatment of uncomplicated falciparum malaria in Kenyan children.
    Varo R; Bassat Q
    Lancet Infect Dis; 2021 Oct; 21(10):1338-1339. PubMed ID: 34111411
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of oral artesunate and quinine plus tetracycline in acute uncomplicated falciparum malaria.
    Karbwang J; Na-Bangchang K; Thanavibul A; Bunnag D; Chongsuphajaisiddhi T; Harinasuta T
    Bull World Health Organ; 1994; 72(2):233-8. PubMed ID: 8205643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of artesunate-amodiaquine (Camoquin plus) versus artemether-lumefantrine (Coartem) against uncomplicated Plasmodium falciparum malaria: multisite trial in Senegal and Ivory Coast.
    Faye B; Offianan AT; Ndiaye JL; Tine RC; Touré W; Djoman K; Sylla K; Ndiaye PS; Penali L; Gaye O
    Trop Med Int Health; 2010 May; 15(5):608-13. PubMed ID: 20214761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azithromycin combination therapy for the treatment of uncomplicated falciparum malaria in Bangladesh: an open-label randomized, controlled clinical trial.
    Thriemer K; Starzengruber P; Khan WA; Haque R; Marma AS; Ley B; Vossen MG; Swoboda P; Akter J; Noedl H
    J Infect Dis; 2010 Aug; 202(3):392-8. PubMed ID: 20557237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artemether-lumefantrine: an option for malaria.
    Stover KR; King ST; Robinson J
    Ann Pharmacother; 2012 Apr; 46(4):567-77. PubMed ID: 22496476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomised, double-blind clinical phase II trial of the efficacy, safety, tolerability and pharmacokinetics of a single dose combination treatment with artefenomel and piperaquine in adults and children with uncomplicated Plasmodium falciparum malaria.
    Macintyre F; Adoke Y; Tiono AB; Duong TT; Mombo-Ngoma G; Bouyou-Akotet M; Tinto H; Bassat Q; Issifou S; Adamy M; Demarest H; Duparc S; Leroy D; Laurijssens BE; Biguenet S; Kibuuka A; Tshefu AK; Smith M; Foster C; Leipoldt I; Kremsner PG; Phuc BQ; Ouedraogo A; Ramharter M;
    BMC Med; 2017 Oct; 15(1):181. PubMed ID: 28988541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.